Search
Find a recruiting study
7,120 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 26, 2026). No sign-up needed.
Most recently updated studies · page 10 of 297
- RecruitingHealthy volunteersPhase 1
A Study to Learn More About the Safety of BIIB145 and How it is Processed in the Body of Healthy Adult Participants
Biogen
- Location
- Austin, TX
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses
Aptabio Therapeutics, Inc.
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–50
- RecruitingHealthy volunteersPhase 1
A Safety Study of IVMED-85 Ophthalmic Solution in Healthy Adults
iVeena Delivery Systems, Inc.
- Location
- Memphis, TN
- Eligibility basics
- Ages 18–49
- RecruitingHealthy volunteersEarly Phase 1
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
MediBeacon
- Location
- Ann Arbor, MI
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1
A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects
Shine-On Biomedical Co., Ltd.
- Location
- Baltimore, MD
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersEarly Phase 1
Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
Neurosterix
- Location
- Los Alamitos, CA
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
Study of MAR002 in Healthy Men
Marea Therapeutics
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–40 · Men only
- RecruitingHealthy volunteersPhase 1
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
AbbVie
- Location
- Grayslake, IL
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.
Bristol-Myers Squibb
- Location
- Anaheim, CA
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
Centessa Pharmaceuticals (UK) Limited
- Location
- Lincoln, NE + 2 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1
Clofutriben Pharmacokinetics in Patients With Impaired Renal Function
Sparrow Pharmaceuticals
- Location
- Orlando, FL
- Eligibility basics
- Ages 18–83
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
ViiV Healthcare
- Location
- Las Vegas, NV + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® Plus
ChromaDex, Inc.
- Location
- Miami, FL
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1
The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy…
Aspargo Labs, Inc
- Location
- New York, NY
- Eligibility basics
- Ages 20–70 · Men only
- RecruitingHealthy volunteersPhase 1
First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults
Inventprise Inc.
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–49
- RecruitingHealthy volunteersPhase 1
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
Mirador Therapeutics, Inc.
- Location
- San Diego, CA
- Eligibility basics
- Ages 19–55
- RecruitingHealthy volunteersPhase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
ViiV Healthcare
- Location
- Las Vegas, NV + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers
Antidote Therapeutics, Inc
- Location
- Overland Park, KS
- Eligibility basics
- Ages 23–59
- RecruitingHealthy volunteersPhase 1/Phase 2
An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera
Urmila DIwekar
- Location
- Houston, TX + 1 other US site
- Eligibility basics
- Ages 20–50 · Women only
- RecruitingHealthy volunteersPhase 1
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
Novo Nordisk A/S
- Location
- Baltimore, MD
- Eligibility basics
- Ages 35–75
- RecruitingHealthy volunteersPhase 1
A Study of IBI3032 in Healthy Participants
Fortvita Biologics (USA)Inc.
- Location
- Lenexa, KS
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Vega Therapeutics, Inc
- Location
- Los Angeles, CA + 9 other US sites
- Eligibility basics
- Ages 12–60
- RecruitingHealthy volunteersPhase 1
Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever
HDT Bio
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1
Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI)
Exelixis
- Location
- Orlando, FL + 1 other US site
- Eligibility basics
- Ages 18–75
Data source: deploy-time snapshot of the ClinicalTrials.gov API. How we list studies